Novo Nordisk (NVO) stock was down pre-market after the company missed on top and bottom lines of second quarter earnings Wednesday. The report comes just a week after the company announced a downward ...

The tech trade is proving resilient, even unstoppable, while the firms that gained by helping people lose weight are ...

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers. Download the app ...

I’ve had a very eventful year. At the beginning of 2025, my long-term relationship ended, and after a few months, I decided ...

Novo Nordisk cautioned on Wednesday that it expects continued competition this year from copycat versions of its Wegovy ...

The Milwaukee Bucks Health and Wellness program is celebrating its one-year anniversary. The free medical program was ...

Linda Yaccarino, the former X CEO who left the social media company in the wake of yet another Elon Musk controversy, has ...

The post, at the company that focuses on care for GLP-1 users, comes after Yaccarino left Elon Musk's X in July.

A new drug that skips neurons and targets support cells cut weight and improved insulin response in lab animals, without ...

Lawsuits from at least 26 patients have been filed in Marion County against Eli Lilly and Co. for its marketing of the drugs ...

Linda Yaccarino, the former CEO of Elon Musk's social media platform X, announced she had a new job on Tuesday -- but her ...

(Reuters) -Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product ...